{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:27:45Z","timestamp":1777429665985,"version":"3.51.4"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.msard.2024.105559","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T08:14:18Z","timestamp":1710836058000},"page":"105559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Brain and spinal cord atrophy in NMOSD and MOGAD: Current evidence and future perspectives"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2050-2908","authenticated-orcid":false,"given":"L.","family":"Lorefice","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Cortese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.msard.2024.105559_bib0001","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.nic.2016.12.010","article-title":"Neuromyelitis optica spectrum disorders","volume":"27","author":"Akaishi","year":"2017","journal-title":"Neuroimaging Clin. N. Am."},{"key":"10.1016\/j.msard.2024.105559_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105150","article-title":"Utility of the 2023 international MOGAD panel proposed criteria in clinical practice: an institutional cohort","volume":"81","author":"Alaboudi","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105559_bib0003","article-title":"A longitudinal analysis of brain volume changes in myelin oligodendrocyte glycoprotein antibody-associated disease","author":"Amin","year":"2023","journal-title":"J. Neuroimaging"},{"issue":"3","key":"10.1016\/j.msard.2024.105559_bib0004","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody- associated disease: international MOGAD Panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.msard.2024.105559_bib0005","doi-asserted-by":"crossref","first-page":"e33878","DOI":"10.1371\/journal.pone.0033878","article-title":"White matter atrophy and cognitive dysfunctions in neuromyelitis optica","volume":"7","author":"Blanc","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.msard.2024.105559_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104787","article-title":"Clinical course, imaging, and pathological features of 45 adult and pediatric cases of myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"76","author":"Boudjani","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"12","key":"10.1016\/j.msard.2024.105559_bib0007","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1111\/ene.15073","article-title":"Volume of hippocampal subfields and cognitive deficits in neuromyelitis optica spectrum disorders","volume":"28","author":"Cacciaguerra","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2024.105559_bib0008","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ncl.2023.06.009","article-title":"Updates in NMOSD and MOGAD diagnosis and treatment: a tale of two central nervous system autoimmune inflammatory disorders","volume":"42","author":"Cacciaguerra","year":"2024","journal-title":"Neurol. Clin."},{"issue":"12","key":"10.1016\/j.msard.2024.105559_bib0009","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.37833","article-title":"Frequency of new silent MRI lesions in myelin oligodendrocyte glycoprotein antibody disease and aquaporin-4 antibody neuromyelitis optica spectrum disorder","volume":"4","author":"Camera","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.msard.2024.105559_bib0010","doi-asserted-by":"crossref","first-page":"fcz026","DOI":"10.1093\/braincomms\/fcz026","article-title":"Imaging markers of disability in aquaporin-4 immunoglobulin G seropositive neuromyelitis optica: a graph theory study","volume":"1","author":"Chien","year":"2019","journal-title":"Brain Commun."},{"issue":"14","key":"10.1016\/j.msard.2024.105559_bib0011","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1177\/1352458518815596","article-title":"Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity","volume":"25","author":"Chien","year":"2019","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.msard.2024.105559_bib0012","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1474-4422(18)30460-5","article-title":"Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders","volume":"18","author":"Ciccarelli","year":"2019","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.msard.2024.105559_bib0013","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1093\/brain\/awac480","article-title":"Clinical and MRI measures to identify non- acute MOG-antibody disease in adults","volume":"146","author":"Cortese","year":"2023","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.msard.2024.105559_bib0014","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1212\/WNL.0000000000201465","article-title":"Differentiating multiple sclerosis from AQP4-neuromyelitis optica spectrum disorder and MOG- antibody disease with imaging","volume":"100","author":"Cortese","year":"2023","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.msard.2024.105559_bib0015","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.20851","article-title":"Quantifying axonal loss after optic neuritis with optical coherence tomography","volume":"59","author":"Costello","year":"2006","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2024.105559_bib0016","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1016\/j.ejrad.2011.01.065","article-title":"Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: a voxel-based morphometry study","volume":"81","author":"Duan","year":"2012","journal-title":"Eur. J. Radiol."},{"issue":"7","key":"10.1016\/j.msard.2024.105559_bib0017","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/jnnp-2020-324826","article-title":"Brain structural alterations in MOG antibody diseases: a comparative study with AQP4 seropositive NMOSD and MS","volume":"92","author":"Duan","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2024.105559_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.1011579","article-title":"Myelitis features and outcomes in CNS demyelinating disorders: comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD","volume":"13","author":"Fadda","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2024.105559_bib0019","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.540156","article-title":"AQP4-IgG and MOG-IgG related optic neuritis-prevalence, optical coherence tomography findings, and visual outcomes: a systematic review and meta-analysis","volume":"11","author":"Filippatou","year":"2020","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2024.105559_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-014-7340-9","article-title":"MRI measures of neurodegeneration in multiple sclerosis: implications for disability, disease monitoring, and treatment","volume":"262","author":"Filippi","year":"2015","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2024.105559_bib0021","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/WCO.0000000000000572","article-title":"MRI in multiple sclerosis: what is changing?","volume":"31","author":"Filippi","year":"2018","journal-title":"Curr. Opin. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2024.105559_bib0022","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1212\/NXI.0000000000000229","article-title":"Normal volumes and microstructural integrity of deep gray matter structures in AQP4+ NMOSD","volume":"3","author":"Finke","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"3","key":"10.1016\/j.msard.2024.105559_bib0023","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/WCO.0000000000000694","article-title":"Neuromyelitis optica spectrum disorders: still evolving and broadening","volume":"32","author":"Fujihara","year":"2019","journal-title":"Curr. Opin. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2024.105559_bib0024","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/ene.13224","article-title":"Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosis","volume":"24","author":"Hyun","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2024.105559_bib0025","article-title":"Multiple sclerosis","author":"Jakimovski","year":"2023","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.msard.2024.105559_bib0026","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrneurol.2015.80","article-title":"Spinal cord MRI in multiple sclerosis diagnostic, prognostic and clinical value","volume":"11","author":"Kearney","year":"2015","journal-title":"Nat. Rev. Neurol."},{"issue":"10","key":"10.1016\/j.msard.2024.105559_bib0027","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1177\/1352458510376640","article-title":"Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity","volume":"16","author":"Kim","year":"2010","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.msard.2024.105559_bib66","doi-asserted-by":"crossref","first-page":"9180","DOI":"10.1038\/s41598-017-08889-9","article-title":"Multimodal magnetic resonance imaging in relation to cognitive impairment in neuromyelitis optica spectrum disorder","volume":"7","author":"Kim","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.msard.2024.105559_bib0028","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1212\/NXI.0000000000000163","article-title":"Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS","volume":"2","author":"Kim","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"7","key":"10.1016\/j.msard.2024.105559_bib0029","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/ene.13011","article-title":"Widespread cortical thinning in patients with neuromyelitis optica spectrum disorder","volume":"23","author":"Kim","year":"2016","journal-title":"Eur. J. Neurol."},{"issue":"11","key":"10.1016\/j.msard.2024.105559_bib0030","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.msard.2024.105559_bib0031","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/jmri.25866","article-title":"Differential brainstem atrophy patterns in multiple sclerosis and neuromyelitis optica spectrum disorders","volume":"47","author":"Lee","year":"2018","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.msard.2024.105559_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2023.578218","article-title":"Serum neurofilament light chain predicts spinal cord atrophy in neuromyelitis optica spectrum disorder","volume":"384","author":"Li","year":"2023","journal-title":"J. Neuroimmunol."},{"issue":"9","key":"10.1016\/j.msard.2024.105559_bib0033","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1007\/s00330-014-3239-1","article-title":"Cortical thinning correlates with cognitive change in multiple sclerosis but not in neuromyelitis optica","volume":"24","author":"Liu","year":"2014","journal-title":"Eur. Radiol."},{"issue":"14","key":"10.1016\/j.msard.2024.105559_bib0034","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1212\/WNL.0000000000001441","article-title":"Differential patterns of spinal cord and brain atrophy in NMO and MS","volume":"84","author":"Liu","year":"2015","journal-title":"Neurology"},{"issue":"17","key":"10.1016\/j.msard.2024.105559_bib0035","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1212\/WNL.0000000000002067","article-title":"Structural MRI substrates of cognitive impairment in neuromyelitis optica","volume":"85","author":"Liu","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2024.105559_bib0036","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s00330-017-4921-x","article-title":"Different patterns of longitudinal brain and spinal cord changes and their associations with disability progression in NMO and MS","volume":"28","author":"Liu","year":"2018","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.msard.2024.105559_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104436","article-title":"Volumetric brain changes in MOGAD: a cross-sectional and longitudinal comparative analysis","volume":"69","author":"Lotan","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.msard.2024.105559_bib0038","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/brain\/awaa347","article-title":"Quantitative spinal cord MRI in MOG-antibody disease, neuromyelitis optica and multiple sclerosis","volume":"144","author":"Mariano","year":"2021","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.msard.2024.105559_bib0039","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/jnnp-2021-326386","article-title":"Silent progression of brain atrophy in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder","volume":"93","author":"Masuda","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.msard.2024.105559_bib0040","doi-asserted-by":"crossref","first-page":"12631","DOI":"10.1038\/s41598-023-38893-1","article-title":"Higher longitudinal brain white matter atrophy rate in aquaporin-4 IgG-positive NMOSD compared with healthy controls","volume":"13","author":"Masuda","year":"2023","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.msard.2024.105559_bib0041","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/13524585211018987","article-title":"Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis","volume":"28","author":"Messina","year":"2022","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2024.105559_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2024.122909","article-title":"Predictors of relapsing disease course following index event in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)","volume":"458","author":"Molazadeh","year":"2024","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2024.105559_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105093","article-title":"Progression independent of relapses in aquaporin4-IgG-seropositive neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, and multiple sclerosis","volume":"80","author":"Molazadeh","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"3","key":"10.1016\/j.msard.2024.105559_bib0044","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/ana.26440","article-title":"Longitudinal retinal changes in MOGAD","volume":"92","author":"Oertel","year":"2022","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.msard.2024.105559_bib67","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/jnnp-2018-320249","article-title":"Attack-related damage of thalamic nuclei in neuromyelitis optica spectrum disorders","volume":"90","author":"Papadopoulou","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"key":"10.1016\/j.msard.2024.105559_bib0045","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/archneur.63.7.964","article-title":"Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression","volume":"63","author":"Pittock","year":"2006","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2024.105559_bib0046","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/jnnp-2017-316880","article-title":"Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination","volume":"89","author":"Ramanathan","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2024.105559_bib0047","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.867190","article-title":"Volumetric brain loss correlates with a relapsing MOGAD disease course","volume":"13","author":"Rechtman","year":"2022","journal-title":"Front. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2024.105559_bib0048","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.221512","article-title":"Emerging perspectives on MRI application in multiple sclerosis: moving from pathophysiology to clinical practice","volume":"307","author":"Rocca","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.msard.2024.105559_bib0049","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/glia.21177","article-title":"Aquaporin-4 MZ isoform: brain expression, supramolecular assembly and neuromyelitis optica antibody binding","volume":"59","author":"Rossi","year":"2011","journal-title":"Glia"},{"issue":"7","key":"10.1016\/j.msard.2024.105559_bib0050","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1212\/01.wnl.0000342478.46908.79","article-title":"Brain atrophy as an outcome measure for multiple sclerosis clinical trials: a \"no-brainer\"?","volume":"72","author":"Rudick","year":"2009","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.msard.2024.105559_bib0051","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ana.24487","article-title":"Optical coherence tomography reflects brain atrophy in multiple sclerosis: a four-year study","volume":"78","author":"Saidha","year":"2015","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2024.105559_bib0052","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41582-020-0314-x","article-title":"MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice","volume":"16","author":"Sastre-Garriga","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2024.105559_bib0053","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.499910","article-title":"Differences in advanced magnetic resonance imaging in MOG-IgG and AQP4-IgG seropositive neuromyelitis optica spectrum disorders: a comparative study","volume":"11","author":"Schmidt","year":"2020","journal-title":"Front. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2024.105559_bib0054","doi-asserted-by":"crossref","first-page":"e66151","DOI":"10.1371\/journal.pone.0066151","article-title":"Optical coherence tomography reveals distinct patterns of retinal damage in neuromyelitis optica and multiple sclerosis","volume":"8","author":"Schneider","year":"2013","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.msard.2024.105559_bib0055","doi-asserted-by":"crossref","first-page":"e1097","DOI":"10.1212\/WNL.0000000000012467","article-title":"Comparison of MRI lesion evolution in different central nervous system demyelinating disorders","volume":"97","author":"Sechi","year":"2021","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.msard.2024.105559_bib0056","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1212\/WNL.0b013e3182648bc8","article-title":"Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis","volume":"79","author":"Sinnecker","year":"2012","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.msard.2024.105559_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103465","article-title":"A comprehensive review of the advances in neuromyelitis optica spectrum disorder","volume":"22","author":"Siriratnam","year":"2023","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.msard.2024.105559_bib0058","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ana.24018","article-title":"Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis","volume":"75","author":"Sormani","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2024.105559_bib0059","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3389\/fneur.2020.00872","article-title":"Cortical thinning and ventricle enlargement in neuromyelitis optica spectrum disorders","volume":"11","author":"Tian","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2024.105559_bib0060","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2023-332663","article-title":"Long-term disability progression in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: a retrospective analysis of 101 patients","author":"Uzawa","year":"2024","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"9","key":"10.1016\/j.msard.2024.105559_bib0061","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1177\/1352458520964415","article-title":"Brain structural and functional alterations in MOG antibody disease","volume":"27","author":"Zhuo","year":"2021","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2024.105559_bib0062","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12883-014-0246-4","article-title":"Comparison of clinical characteristics between neuromyelitis optica spectrum disorders with and without spinal cord atrophy","volume":"14","author":"Wang","year":"2014","journal-title":"BMC Neurol."},{"key":"10.1016\/j.msard.2024.105559_bib0063","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/cen3.12107","article-title":"Evaluation of aquaporin-4 antibody assays","volume":"5","author":"Waters","year":"2014","journal-title":"Clin. Exp. Neuroimmunol."},{"issue":"10","key":"10.1016\/j.msard.2024.105559_bib0064","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2024.105559_bib0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482400138X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482400138X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T11:41:24Z","timestamp":1738064484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221103482400138X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":67,"alternative-id":["S221103482400138X"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2024.105559","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain and spinal cord atrophy in NMOSD and MOGAD: Current evidence and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2024.105559","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105559"}}